RECRUITING

MDCT vs. CBCT Guided Percutaneous Lung Nodule Biopsy: A Comparison of Pneumothorax Incidence and Associated Risk Factors

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this study is to determine if cone beam computed tomography (CBCT) is a viable alternative imaging guidance modality for percutaneous transthoracic needle biopsy (PTNB) in a community hospital-based practice, and to determine the incidence of CBCT PTNB-associated pneumothorax compared to multidetector computed tomography (MDCT) guided PTNB biopsy. The standard of care in this facility is MDCT guided PTNB biopsy. The experimental arm of this study is CBCT-guided PTNB biopsy. This prospective study will identify patients planned for PTNB. Thereafter, data on lesion characteristics, imaging findings, and clinical history will be collected. Patients will be subsequently randomly assigned to undergo biopsy using either CBCT or MDCT guidance. This study will analyze the pneumothorax incidence between groups, and assess for associations between lesion size/location, pertinent imaging findings, and clinical risk factors.

Official Title

CT Guided and Cone Beam CT Guided Percutaneous Transthoracic Needle Biopsy: A Comparison of Pneumothorax Incidence and Associated Risk Factors

Quick Facts

Study Start:2021-07-08
Study Completion:2024-07-08
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05344430

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 90 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients scheduled for lung biopsy at Mather Hospital's Department of Interventional Radiology.
  2. * Patients ages from 18 years old to 90 years old.
  1. * High risk patients will be excluded from the study.
  2. * ( High risk - Any patient with severe emphysema with bullous emphysema on baseline Computed Tomography of the Chest, intended biopsy target/nodule adjacent to an airway or central vasculature, or less than 1 cm in size)
  3. * Patients less than 18 years old
  4. * Patients older than 90 years old
  5. * patients who lack mental capacity for medical decision making
  6. * Any patient requiring or requesting general anesthesia for the intended procedure

Contacts and Locations

Study Contact

Kenny Lien, MD
CONTACT
631-473-1320
klien@northwell.edu
Greg Haggerty, PhD
CONTACT
516-551-8655
ghaggerty@northwell.edu

Principal Investigator

Kenny Lien, MD
PRINCIPAL_INVESTIGATOR
Interventional Radiologist

Study Locations (Sites)

Mather Hospital Northwell Health
Port Jefferson, New York, 11777
United States

Collaborators and Investigators

Sponsor: Northwell Health

  • Kenny Lien, MD, PRINCIPAL_INVESTIGATOR, Interventional Radiologist

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-07-08
Study Completion Date2024-07-08

Study Record Updates

Study Start Date2021-07-08
Study Completion Date2024-07-08

Terms related to this study

Additional Relevant MeSH Terms

  • Lung Diseases